Gene53
ACP2: acid phosphatase 2, lysosomal
Cite this record
ConductScience Library. ACP2: acid phosphatase 2, lysosomal. Genes, record 53. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/53
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P11117 | Lysosomal acid phosphatase | 423 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents125
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260259214 A1 | 2026-09-03 | 16 | P11117 | Espacenet |
| US 20260201011 A1 | 2026-07-16 | 137 | P11117 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 236 | P11117 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5354 | P11117 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 137 | P11117 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 137 | P11117 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36027 | P11117 | Espacenet |
| US 20250387462 A1 | 2025-12-25 | 392 | P11117 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1613 | P11117 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 75377 | P11117 | Espacenet |
NIH grants492
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ACP2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 2 | 2025 |
| P30EY001792 | P30 Core Grant for Vision Research | 2 | 2025 |
| R01AG050986 | Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | 2 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 2 | 2025 |
| T32HG009495 | Postdoctoral Training Program in Genomic Medicine | 2 | 2025 |
| ZIAHD008814 | Mammalian iron-sulfur cluster biogenesis | 2 | 2025 |
| ZIAHL006170 | Cardiovascular Genomics and Bioinformatics projects | 2 | 2025 |
| K01AG072044 | Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study | 1 | 2025 |
Source NIH's project files
Papers518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A pan-genome perspective uncovers the core genetic basis and evolutionary adaptation of lipid synthesis and vesicular transport in Nannochloropsis. | J Phycol | 2026 | 42615245 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies ACP2 as a lysosome-associated biomarker linked to immune dynamics and clinical outcomes in glioma. | Comput Biol Chem | 2026 | 42308869 | PubTator, text mining | PubMed |
| Exploratory identification of lycorine as a potential inhibitor of the ACP2/YME1L1 prognostic axis in esophageal squamous cell carcinoma: a multi-omics and computational hypothesis. | Mol Genet Genomics | 2026 | 41940976 | PubTator, text mining | PubMed |
| Mechanism of ribosome stalling by the AMD1 C-terminal tail arrest peptide. | Sci Adv | 2026 | 41894501 | PubTator, text mining | PubMed |
| Neuroimaging PheWAS and molecular phenotyping implicate PSMC3 in Alzheimer's disease. | Alzheimers Dement | 2026 | 41732108 | PubTator, text mining | PubMed |
| Recent advances in phosphatases as new biomarker in personalized medicine. | Clin Chim Acta | 2026 | 41654008 | PubTator, text mining | PubMed |
| Using multimodal cortical parcellations to identify novel regions of the human cerebral cortex associated with cognitive performance. | Transl Psychiatry | 2026 | 41526333 | PubTator, text mining | PubMed |
| Distinct roles of tandem acyl carrier protein domains in the assembly of a macrocyclic polylactone. | Chem Commun (Camb) | 2025 | 40948200 | PubTator, text mining | PubMed |
| Identification of potential drug targets and possible drugs for esophageal carcinoma from genetic insights: a comprehensive two-sample Mendelian randomization study. | Discov Oncol | 2025 | 40853405 | PubTator, text mining | PubMed |
| High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity. | Sci Rep | 2024 | 39550388 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/53
GET https://conductscience.org/api/genes/v1/53/patents?page=2